Navigation Links
Hospira Reports First-Quarter 2012 Results
Date:5/1/2012

nsed Consolidated Balance Sheets(Unaudited)(dollars in millions)March 31,December 31,Assets20122011Current Assets:Cash and cash equivalents

$
55.9$
597.5Trade receivables, less allowances of $17.0 in 2012 and $15.7 in 2011

625.8639.9Inventories

1,065.01,027.0Deferred income taxes

167.4174.4Prepaid expenses

49.245.9Other receivables

72.786.0Total Current Assets

2,636.02,570.7Property and equipment, net

1,392.81,355.0Intangible assets, net

341.7355.8Goodwill1,088.91,082.9Deferred income taxes

244.3232.2Investments

63.748.7Other assets

141.3133.8Total Assets

$
5,908.7$
5,779.1Liabilities and Shareholders' EquityCurrent Liabilities:Short-term borrowings

$
7.2$
36.6Trade accounts payable

234.4241.3Salaries, wages and commissions

107.6113.0Other accrued liabilities

474.8456.9Total Current Liabilities

884.0847.8Long-term debt

1,712.01,711.9Deferred income taxes

5.45.7Post-retirement obligations and other long-term liabilities

268.4275.7Commitments and ContingenciesTotal Shareholders' Equity

3,038.92,938.0Total Liabilities and Shareholders' Equity

$
5,908.7$
5,779.1Hospira, Inc.Condensed Consolidated Statements of Cash Flows(Unaudited)(dollars in millions)Three months ended March 31,20122011Cash Flow From Operating Activities:  Net income

$
40.2$
49.9  Adjustments to reconcile net income to net cash from operating activities-Depreciation

40.840.8Amortization of intangible assets

21.322.2Stock-based compensation expense

10.413.7Undistributed equity income from affiliates

(13.1)(17.2)Deferred income tax and other tax adjustments

(6.4)(15.1)Impairment and other asset charges

1.66.8  Changes in assets and liabilitiesTrade receivables

22.2(100.8)Inventories

(35
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Joins the Generic Pharmaceutical Association
3. Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Months Supply of New Product Immediately and on Track to Ensure Sustainable Supply
4. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
5. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
6. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
7. Hospira Reports Third-Quarter 2011 Results
8. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
9. Hospira to Host Conference Call for Third-Quarter 2011 Results
10. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
11. Hospira to Host 2011 Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... BreedIT Ltd., the exclusive worldwide distributor of highly sophisticated ... that on January 7, 2014, the Company,s board of ... Ben-Zion Weiner as its new member of the ...
(Date:1/15/2014)... Inc. (Nasdaq: ECTE ) ("Echo"), a medical ... non-invasive, wireless continuous glucose monitoring system, today announced that ... CEO of Echo Therapeutics, will present at "TEN", Noble ... Mr. Doman will make a corporate presentation to ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... 5, 2011 Nektar Therapeutics (Nasdaq: NKTR ... patients in a Phase 2 clinical study evaluating single-agent ... of 33 women in the study with prior Doxil® ... response rate using either RECIST 1.0 criteria (response by ...
... CHICAGO, June 4, 2011 Genomic Health, Inc. (Nasdaq: ... studies being presented at the American Society of Clinical ... study confirming the performance of the Onco type ... predictor of recurrence risk in stage II colon cancer. ...
Cached Medicine Technology:NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 2NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 3NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 4NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 5NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 6NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 7NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 8Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 2Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 3Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 4Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 5Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 6Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 7Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 8Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 9
(Date:7/11/2014)... The Williams Rejuva Center excited to ... patient’s unique treatment regime. Using the Vectra 3D ... trouble areas can be quickly created. The evaluation ... , Vectra 3D is a cutting-edge computer imaging system. ... a quick ‘snapshot’ of the skin to determine the ...
(Date:7/11/2014)... 11, 2014 Even the hot Texas sun ... Elementary School . The school had previously invested ... equipment from APCPLAY, but recently asked for an innovative ... , Godley Elementary School chose a Rectangular Shade from ... for children on their playground. The shade measures 24’W ...
(Date:7/11/2014)... July 11, 2014 Shu Cosmetic ... perineplasty for each qualifying patient undergoing a ... been performing laser vaginal rejuvenation, an advanced type ... The LVR procedure decreases the internal and external ... muscle tone, strength, and control, resulting in enhanced ...
(Date:7/11/2014)... ASHBURN PSYCHOLOGICAL AND PSYCHIATRIC SERVICES , On July 1st, Senate ... disability or autism to have a special code placed on ... law enforcement or first responders that they are dealing with ... a central Virginia mother, Ms. Pam Mines, who wanted to ... JP. During a news conference after the law passed, ...
(Date:7/10/2014)... (PRWEB) July 11, 2014 Karen Middleton, ... President and CEO of Planned Parenthood of the Rocky ... Senator Mark Udall and Representative Diana DeGette were in ... Court’s Hobby Lobby decision and keeping bosses out of ... representatives listened to the president today in Denver addressing ...
Breaking Medicine News(10 mins):Health News:Williams Rejuva Center Includes Innovative Computer Imaging 2Health News:Cool Fun Under the Texas Sun: Godley Elementary School Purchases Shade Structure from APCPLAY© 2Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 2Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 3Health News:Recent Special “Autism” Code on Virginia Driver’s Licenses and ID Cards Goes into Law: Helpful or Discriminatory for Individuals on the Autistic Spectrum? 2Health News:Recent Special “Autism” Code on Virginia Driver’s Licenses and ID Cards Goes into Law: Helpful or Discriminatory for Individuals on the Autistic Spectrum? 3Health News:Naral Pro-Choice Colorado & Planned Parenthood Of The Rocky Mountains Statement On Udall & Degette Staying In Dc To Introduce Legislation 2
... ... for the Apple® iPhone. Module is the world’s first all-purpose iPhone case to ... ... February 24, 2010 -- Dacha Works LLC , the mobile computing accessories company, ...
... ... Company’s Future Growth , ... (PRWEB) March 17, 2010 -- Group Logic, a leading provider of desktop ... the company’s new chief executive officer (CEO). As a software industry veteran, Broderick ...
... Highly educated white men most likely to be tipplers, study ... to two-thirds (61 percent) of American adults consider themselves drinkers, ... likely to drink alcohol than women, and people with more ... of U.S. residents say they,ve abstained their whole lives. ...
... ... pharmacists with valuable information on topics such as operations management, economic analysis, reimbursement ... human resource strategies – vital competencies for pharmacy leaders and managers. , ... Sudbury, MA ...
... ... and high rates of asthma in Washington, DC. , ... Washington, DC (Vocus) March 17, 2010 -- Researchers ... asthma in metropolitan Washington, DC, are significantly more likely to have low levels of ...
... Worldwide Edition for his outstanding contributions and achievements in the field of healthcare. , ... , ... ... , ...
Cached Medicine News:Health News:Dacha Works Introduces Module- A Revolution In iPhone Case Design 2Health News:Group Logic, Inc. Appoints New CEO 2Health News:Group Logic, Inc. Appoints New CEO 3Health News:6 Out of 10 American Adults Drink 2Health News:New Book Reviews Core Competencies for Pharmacy Leaders 2Health News:New Book Reviews Core Competencies for Pharmacy Leaders 3Health News:New Book Reviews Core Competencies for Pharmacy Leaders 4Health News:Study: Low Levels of Vitamin D Linked to Higher Rates of Asthma in African American Kids 2Health News:Study: Low Levels of Vitamin D Linked to Higher Rates of Asthma in African American Kids 3Health News:Dr. Mark Russell Recognized By Strathmore's Who's Who Worldwide Publication 2
... for catheter or instrument introduction. The ... be peeled away and removed. The ... instrument to be introduced should be ... the sheath. Supplied sterile in peel-open ...
Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
... Used to provide ... or epispadias repair. The ... to partially close during ... urethra while maintaining urethral ...
... temporary internal drainage from ... the bladder. Supplied sterile ... for one-time use. CAUTION: ... C-Flex® and Sof-Flex® stents ...
Medicine Products: